Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.6 appears on the page, signaling a minor update to the page version. This does not alter the study details or other visible content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision label advanced from v3.6.4 to v3.6.5, indicating a new version of the page's metadata for the study record. This reflects an update to the page documentation rather than substantive changes to the study content.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page shows a revision label updated from v3.6.3 to v3.6.4, signaling a new release of the site's software rather than a modification to trial data.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the page's versioning. It does not reflect changes to the study content or visible functionality.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision was updated from v3.6.0 to v3.6.2, indicating a backend or formatting update to the study record page rather than a change to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedRecruitment status now shows closure for participants, and additional help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The revision note was updated to v3.6.0 and a related heading change was made.SummaryDifference0.5%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.